{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:35:58Z","timestamp":1768826158119,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13104-019-4319-8","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T13:26:14Z","timestamp":1558617974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0958-5212","authenticated-orcid":false,"given":"Ameen Abdulaziz","family":"Basabaeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enaam Abdelrhman","family":"Abdelgader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othman Saeed","family":"BaHashwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtihal Ahmed","family":"Babekir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour Mahmoud","family":"Abdelateif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salem Ahmed","family":"Bamusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadia Osman","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama Ali","family":"Altayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Abbass","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Khider","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"issue":"8","key":"4319_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352(8):804\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"4319_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.anndiagpath.2007.08.002","volume":"11","author":"KV Inamdar","year":"2007","unstructured":"Inamdar KV, Bueso-Ramos CE. Pathology of chronic lymphocytic leukemia: an update. Ann Diagn Pathol. 2007;11(5):363\u201389.","journal-title":"Ann Diagn Pathol"},{"issue":"8","key":"4319_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.4065\/81.8.1105","volume":"81","author":"KW Yee","year":"2006","unstructured":"Yee KW, O\u2019Brien SM. Chronic lymphocytic leukemia: diagnosis and treatment. Mayo Clin Proc. 2006;81(8):1105\u201329.","journal-title":"Mayo Clin Proc"},{"key":"4319_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1182\/asheducation-2003.1.153","volume":"2003","author":"MJ Keating","year":"2003","unstructured":"Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, Ferrarini M, Kipps TJ. Biology and treatment of chronic lymphocytic leukemia. Hematology. 2003;2003:153\u201375.","journal-title":"Hematology"},{"issue":"4","key":"4319_CR5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1182\/blood-2003-07-2281","volume":"103","author":"TD Shanafelt","year":"2004","unstructured":"Shanafelt TD, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood. 2004;103(4):1202\u201310.","journal-title":"Blood"},{"issue":"2","key":"4319_CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219\u201334.","journal-title":"Blood"},{"issue":"1","key":"4319_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","volume":"48","author":"JL Binet","year":"1981","unstructured":"Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48(1):198\u2013206.","journal-title":"Cancer"},{"issue":"6","key":"4319_CR8","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848\u201354.","journal-title":"Blood"},{"issue":"11","key":"4319_CR9","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood.V89.11.4153","volume":"89","author":"DG Oscier","year":"1997","unstructured":"Oscier DG, Thompsett A, Zhu D, Stevenson FK. Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood. 1997;89(11):4153\u201360.","journal-title":"Blood"},{"issue":"4","key":"4319_CR10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","volume":"100","author":"DG Oscier","year":"2002","unstructured":"Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, Corcoran MM, Chapman RM, Thomas PW, Copplestone JA, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. 2002;100(4):1177\u201384.","journal-title":"Blood"},{"issue":"4","key":"4319_CR11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","volume":"100","author":"A Krober","year":"2002","unstructured":"Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, Dohner H, Stilgenbauer S. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100(4):1410\u20136.","journal-title":"Blood"},{"issue":"6","key":"4319_CR12","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94(6):1840\u20137.","journal-title":"Blood"},{"key":"4319_CR13","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.leukres.2011.07.020","volume":"35","author":"TJ Hamblin","year":"2011","unstructured":"Hamblin TJ. Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia. Leuk Res. 2011;35:1432\u20135.","journal-title":"Leuk Res"},{"issue":"3","key":"4319_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","volume":"99","author":"TJ Hamblin","year":"2002","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99(3):1023\u20139.","journal-title":"Blood"},{"issue":"18","key":"4319_CR15","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003;348(18):1764\u201375.","journal-title":"N Engl J Med"},{"issue":"5","key":"4319_CR16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/sj.leu.2403707","volume":"19","author":"R Schroers","year":"2005","unstructured":"Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Duhrsen U, Durig J. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia. 2005;19(5):750\u20138.","journal-title":"Leukemia"},{"issue":"12","key":"4319_CR17","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446\u201356.","journal-title":"Blood"},{"issue":"1","key":"4319_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13104-019-4239-7","volume":"12","author":"AA Basabaeen","year":"2019","unstructured":"Basabaeen AA, Abdelgader EA, Babekir EA, Eltayeb NH, Altayeb OA, Fadul EA, Bahashwan OS, Ibrahim IK. Clinical presentation and hematological profile among young and old chronic lymphocytic leukemia patients in Sudan. BMC Res Notes. 2019;12(1):202.","journal-title":"BMC Res Notes"},{"key":"4319_CR19","unstructured":"Beckman Coulter I. COULTER\u00ae EPICS\u00ae XL\u2122 Flow Cytometer. 2010."},{"issue":"5","key":"4319_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bjh.12067","volume":"159","author":"D Oscier","year":"2012","unstructured":"Oscier D, Dearden C, Eren E, et al. Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. Br J Haematol. 2012;159(5):541\u201364.","journal-title":"Br J Haematol"},{"issue":"10","key":"4319_CR21","first-page":"1640","volume":"8","author":"E Matutes","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8(10):1640\u20135.","journal-title":"Leukemia"},{"issue":"4","key":"4319_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","volume":"108","author":"EJ Moreau","year":"1997","unstructured":"Moreau EJ, Matutes E, A\u2019Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, Seon BK, Catovsky D. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol. 1997;108(4):378\u201382.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"4319_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.18502\/sjms.v13i4.3593","volume":"13","author":"EA-R Abdel-Gader","year":"2018","unstructured":"Abdel-Gader EA-R, Eltayeb NH, Eltahir TA, Altayeb OA, Fadul EA, Rahman EMA, Merghani TH. ZAP-70 expression in B-chronic lymphocytic leukemia in Sudanese patients. Sudan J Med Sci. 2018;13(4):230\u20139. https:\/\/doi.org\/10.18502\/sjms.v13i4.3593 .","journal-title":"Sudan J Med Sci"},{"issue":"1","key":"4319_CR24","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s13104-018-3926-0","volume":"11","author":"EA Abdelgader","year":"2018","unstructured":"Abdelgader EA, Eltayeb NH, Eltahir TA, Altayeb OA, Fadul EA, Abdel Rahman EM, Merghani TH. Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia. BMC Res Notes. 2018;11(1):815.","journal-title":"BMC Res Notes"},{"issue":"10","key":"4319_CR25","first-page":"2124","volume":"104","author":"I Del Giudice","year":"2005","unstructured":"Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A\u2019hern R. Chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer Interdiscip Int J Am Cancer Soc. 2005;104(10):2124\u201332.","journal-title":"Cancer Interdiscip Int J Am Cancer Soc"},{"issue":"4","key":"4319_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/annonc\/mdj120","volume":"17","author":"I Hus","year":"2006","unstructured":"Hus I, Podhorecka M, Bojarska-Junak A, Roli\u0144ski J, Schmitt M, Sieklucka M, W\u0105sik-Szczepanek E, Dmoszy\u0144ska A. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. Ann Oncol. 2006;17(4):683\u201390.","journal-title":"Ann Oncol"},{"issue":"9","key":"4319_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ajh.20936","volume":"82","author":"G D\u2019arena","year":"2007","unstructured":"D\u2019arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. Am J Hematol. 2007;82(9):787\u201391.","journal-title":"Am J Hematol"},{"issue":"1","key":"4319_CR28","first-page":"627","volume":"83","author":"R Waheed","year":"2015","unstructured":"Waheed R, Mahana N, Kassem N, EL-Deeb S. ZAP70 and CD38 as prognostic markers for chronic lymphocytic leukemia in Egyptian patients. Med J Cairo Univ. 2015;83(1):627\u201332.","journal-title":"Med J Cairo Univ"},{"issue":"4","key":"4319_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4103\/0019-509X.123620","volume":"50","author":"A Gogia","year":"2013","unstructured":"Gogia A, Sharma A, Raina V, Kumar L, Gupta R, Kumar R. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients. Indian J Cancer. 2013;50(4):333.","journal-title":"Indian J Cancer"},{"key":"4319_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cca.2018.04.026","volume":"483","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wang Y, Yang J, Bi Y, Wang H. ZAP-70 in chronic lymphocytic leukemia: a meta-analysis. Clin Chim Acta. 2018;483:82\u20138.","journal-title":"Clin Chim Acta"},{"issue":"9403","key":"4319_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","volume":"363","author":"JA Orchard","year":"2004","unstructured":"Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet. 2004;363(9403):105\u201311.","journal-title":"Lancet"},{"issue":"4","key":"4319_CR32","first-page":"287","volume":"21","author":"M Assem","year":"2009","unstructured":"Assem M, Hamid TA, Kohla A, Arsanyos S. The prognostic significance of combined expression of ZAP-70 and CD38 in chronic lymphocytic leukemia. J Egypt Nat Cancer Inst. 2009;21(4):287\u201397.","journal-title":"J Egypt Nat Cancer Inst"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4319-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4319-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4319-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T14:10:22Z","timestamp":1721311822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4319-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4319"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4319-8","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from the Institutional Review Board at Al Neelain University. Principal investigator obtained written informed consent from all participants prior to their inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}